Soleno Therapeutics (SLNO) Capital Expenditures Growth (3y) (2016 - 2025)
Soleno Therapeutics (SLNO) Capital Expenditures Growth (3y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Soleno Therapeutics |
2.76 Bn |
2.51 Bn |
93.41 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
113.02% |
| Dec 31, 2024 |
-14.94% |
| Sep 30, 2024 |
236.79% |
| Mar 31, 2024 |
40.10% |
| Dec 31, 2022 |
6.27% |
| Dec 31, 2021 |
86.63% |
| Sep 30, 2021 |
0.00% |
| Dec 31, 2020 |
-26.07% |
| Dec 31, 2019 |
39.14% |
| Jun 30, 2019 |
81.71% |
| Mar 31, 2019 |
-19.26% |
| Dec 31, 2018 |
26.16% |
| Sep 30, 2018 |
26.69% |
| Dec 31, 2016 |
-204.72% |
